TransCode Therapeutics (RNAZ) Short Interest Ratio & Short Volume $0.53 +0.05 (+10.46%) (As of 12:38 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends TransCode Therapeutics Short Interest DataTransCode Therapeutics (RNAZ) has a short interest of 1.22 million shares, representing 7.08% of the float (the number of shares available for trading by the public). This marks a -11.59% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.6, indicating that it would take 0.6 days of the average trading volume of 1.29 million shares to cover all short positions.Current Short Interest1,220,000 sharesPrevious Short Interest1,380,000 sharesChange Vs. Previous Month-11.59%Dollar Volume Sold Short$901,580.00Short Interest Ratio0.6 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares17,266,000 sharesFloat Size17,230,000 sharesShort Percent of Float7.08%Today's Trading Volume452,771 sharesAverage Trading Volume1,286,300 sharesToday's Volume Vs. Average35% Short Selling TransCode Therapeutics? Sign up to receive the latest short interest report for TransCode Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRNAZ Short Interest Over TimeRNAZ Days to Cover Over TimeRNAZ Percentage of Float Shorted Over Time Ad Golden CrestCRUSHED: How Biden's Replacement Will Devastate Your 401(k)!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.>> Get Your FREE Wealth Protection Guide << TransCode Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/20241,220,000 shares $901,580.00 -11.6%7.1%0.6 $0.74 9/30/20241,380,000 shares $787,980.00 +52.5%8.0%0.7 $0.57 9/15/2024904,700 shares $234,407.77 +224.7%5.3%0.6 $0.26 8/31/2024278,600 shares $73,383.24 +58.5%1.6%0.2 $0.26 8/15/2024175,800 shares $43,950.00 -89.3%1.0%0.2 $0.25 7/31/20241,640,000 shares $459,200.00 +6,539.7%9.6%1.1 $0.28 Get the Latest News and Ratings for RNAZ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TransCode Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/15/202424,700 shares $22,237.41 -85.2%0.4%0 $0.90 6/30/2024167,200 shares $168,036.00 -62.7%2.5%0.1 $1.01 6/15/2024448,500 shares $538,200.00 -56.0%6.9%0.4 $1.20 5/31/20241,020,000 shares $1.81 million +486.5%15.6%0.8 $1.78 5/15/2024173,900 shares $140,267.74 +16.2%2.7%0.1 $0.81 4/30/2024149,600 shares $90,822.16 +704.3%2.3%0.2 $0.61 4/15/202418,600 shares $9,975.18 -53.5%0.3%0 $0.54 3/31/202440,000 shares $27,320.00 -77.1%0.6%0.1 $0.68 3/15/2024174,800 shares $120,786.80 +71.4%2.7%0.3 $0.69 2/29/2024102,000 shares $71,869.20 -53.8%1.6%0.2 $0.70 2/15/2024220,900 shares $145,794.00 -70.8%3.4%0.4 $0.66 1/31/2024755,300 shares $521,912.30 +7,529.3%13.0%1.6 $0.69 1/15/20249,900 shares $49,500.00 -97.6%1.8%0 $5.00 12/31/2023405,000 shares $66,744.00 -7.4%N/A0.1 $0.16 12/15/2023437,500 shares $74,156.25 -31.3%2.0%0.1 $0.17 11/30/2023637,200 shares $156,751.20 +31.8%3.0%0.1 $0.25 11/15/2023483,300 shares $138,610.44 -63.4%2.5%0.1 $0.29 10/31/20231,320,000 shares $488,664.00 +562.0%7.4%0.2 $0.37 10/15/2023199,400 shares $86,100.92 +173.9%6.2%0 $0.43 9/30/202372,800 shares $36,596.56 -42.4%4.5%0 $0.50 9/15/2023126,400 shares $84,511.04 +418.0%7.1%0.1 $0.67 8/31/202324,400 shares $35,380.00 +1,255.6%1.7%0.2 $1.45 8/15/20231,800 shares $2,916.00 -87.8%0.1%0 $1.62 7/31/202314,700 shares $32,340.00 -85.5%2.5%0.1 $2.20 7/15/2023101,500 shares $257,810.00 +81.9%16.9%0.4 $2.54 6/30/202355,800 shares $128,340.00 +14.6%9.3%0.2 $2.30 6/15/202348,700 shares $129,055.00 +79.7%8.1%0.2 $2.65 5/31/202327,100 shares $113,820.00 +22.1%4.4%0.2 $4.20 5/15/202322,200 shares $135,109.20 -96.6%N/A0.5 $6.09 4/30/2023653,200 shares $206,345.88 +2.7%5.6%0.4 $0.32 4/15/2023636,000 shares $250,965.60 +99.5%5.5%0.4 $0.39 3/31/2023318,800 shares $107,913.80 +21.0%2.8%0.2 $0.34 3/15/2023263,500 shares $91,618.95 -51.3%2.3%0.2 $0.35 2/28/2023541,400 shares $282,069.40 -42.9%4.7%0.1 $0.52CRUSHED: How Biden's Replacement Will Devastate Your 401(k)! (Ad)Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.>> Get Your FREE Wealth Protection Guide << 2/15/2023948,400 shares $635,428.00 +104.5%7.5%0.2 $0.67 1/31/2023463,700 shares $348,145.96 +0.8%5.3%0.2 $0.75 1/15/2023459,900 shares $281,458.80 -43.5%5.3%0.1 $0.61 12/30/2022814,100 shares $547,889.30 -22.5%9.4%0.3 $0.67 12/15/20221,050,000 shares $472,290.00 +2,849.4%12.1%0.4 $0.45 11/30/202235,600 shares $14,240.00 +368.4%0.4%0 $0.40 11/15/20227,600 shares $4,164.80 -96.5%0.1%0 $0.55 10/31/2022218,800 shares $147,033.60 +478.8%2.5%0.3 $0.67 10/15/202237,800 shares $41,995.80 -2.1%0.4%1.9 $1.11 9/30/202238,600 shares $42,460.00 +565.5%0.4%1.9 $1.10 9/15/20225,800 shares $6,728.00 -29.3%0.1%0.3 $1.16 8/31/20228,200 shares $9,840.00 +90.7%0.1%0.2 $1.20 8/15/20224,300 shares $5,547.00 -66.4%0.1%0.1 $1.29 7/31/202212,800 shares $18,176.00 +1.6%0.2%0.3 $1.42 7/15/202212,600 shares $16,632.00 +26.0%0.1%0.3 $1.32 6/30/202210,000 shares $12,600.00 +1.0%0.1%0.2 $1.26 6/15/20229,900 shares $12,573.00 -52.9%0.1%0.3 $1.27 5/31/202221,000 shares $38,640.00 -15.7%0.2%1.1 $1.84 5/15/202224,900 shares $56,025.00 -46.6%0.3%1.5 $2.25 4/30/202246,600 shares $127,218.00 +88.7%0.5%2.9 $2.73 4/15/202224,700 shares $70,814.90 -44.9%0.3%1.4 $2.87 3/31/202244,800 shares $129,024.00 +37.9%0.5%2 $2.88 3/15/202232,500 shares $70,200.00 -38.2%0.4%0.9 $2.16 2/28/202252,600 shares $112,038.00 -37.8%0.7%1.3 $2.13 2/15/202284,600 shares $181,044.00 -12.6%1.2%1.6 $2.14 1/31/202296,800 shares $222,640.00 -24.7%1.4%1.6 $2.30 1/15/2022128,500 shares $322,535.00 +51.4%1.8%1.6 $2.51 12/31/202184,900 shares $215,646.00 +0.7%1.2%0.7 $2.54 12/15/202184,300 shares $207,378.00 +157.0%1.2%0.3 $2.46 11/30/202132,800 shares $90,200.00 +32.8%0.5%0 $2.75 11/15/202124,700 shares $73,606.00 -86.7%0.4%0 $2.98 10/29/2021185,900 shares $526,097.00 -22.9%2.6%0 $2.83 10/15/2021241,100 shares $776,342.00 -47.1%3.4%0.1 $3.22 9/30/2021455,400 shares $1.36 million +1,350.3%6.4%0.1 $2.99 9/15/202131,400 shares $81,012.00 -39.7%0.4%0 $2.58 8/31/202152,100 shares $158,384.00 +128.5%0.7%0 $3.04 8/13/202122,800 shares $65,436.00 No Change0.4%0 $2.87 RNAZ Short Interest - Frequently Asked Questions What is TransCode Therapeutics' current short interest? Short interest is the volume of TransCode Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 15th, investors have sold 1,220,000 shares of RNAZ short. 7.08% of TransCode Therapeutics' shares are currently sold short. Learn More on TransCode Therapeutics' current short interest. What is a good short interest ratio for TransCode Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RNAZ shares currently have a short interest ratio of 1.0. Learn More on TransCode Therapeutics's short interest ratio. What is a good short interest percentage for TransCode Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.08% of TransCode Therapeutics' floating shares are currently sold short. Is TransCode Therapeutics' short interest increasing or decreasing? TransCode Therapeutics saw a drop in short interest in October. As of October 15th, there was short interest totaling 1,220,000 shares, a drop of 11.6% from the previous total of 1,380,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is TransCode Therapeutics' float size? TransCode Therapeutics currently has issued a total of 17,266,000 shares. Some of TransCode Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. TransCode Therapeutics currently has a public float of 17,230,000 shares. How does TransCode Therapeutics' short interest compare to its competitors? 7.08% of TransCode Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to TransCode Therapeutics: NextCure, Inc. (0.35%), OKYO Pharma Limited (0.76%), Trevena, Inc. (8.55%), Avalon GloboCare Corp. (3.49%), Marker Therapeutics, Inc. (0.95%), Lumos Pharma, Inc. (5.41%), BioLineRx Ltd. (0.78%), Elevation Oncology, Inc. (11.90%), Daré Bioscience, Inc. (0.53%), Estrella Immunopharma, Inc. (0.17%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short TransCode Therapeutics stock? Short selling RNAZ is an investing strategy that aims to generate trading profit from TransCode Therapeutics as its price is falling. RNAZ shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against TransCode Therapeutics? A short squeeze for TransCode Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RNAZ, which in turn drives the price of the stock up even further. How often is TransCode Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RNAZ, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies NextCure Short Interest Data OKYO Pharma Short Interest Data Trevena Short Interest Data Avalon GloboCare Short Interest Data Marker Therapeutics Short Interest Data Lumos Pharma Short Interest Data BioLineRx Short Interest Data Elevation Oncology Short Interest Data Daré Bioscience Short Interest Data Estrella Immunopharma Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RNAZ) was last updated on 11/4/2024 by MarketBeat.com Staff From Our PartnersCRUSHED: How Biden's Replacement Will Devastate Your 401(k)!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a ...Golden Crest | Sponsored[Charles Payne Live Event] Click to Confirm Your RSVPThe Blueprint to Protect Your Portfolio Charles Payne reveals a strategy few investors know about Unstoppable Prosperity | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TransCode Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TransCode Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
